Palantir Technologies (NASDAQ:PLTR) shares climbed about 8% in after-hours trading on Monday after the data analytics firm reported fiscal fourth-quarter results that smashed market expectations. The ...
Bristol Myers Squibb Canada (BMS) today announced that OPDIVO® (nivolumab) in combination with YERVOY® (ipilimumab) ...